Search research articles
Contact Us
Filters
Showing results (21-30 of 34) with videos related to
Page
of 4
Sort By:
BMJ Open
|
January 31, 2024
Descriptive analysis to assess seasonal patterns of COVID-19 and influenza in low-income and middle-income countries in Asia, the Middle East and Latin America
Moe H Kyaw, Julia Regazzini Spinardi, Oladayo Jagun, et al.
Preventing Chronic Disease
|
February 5, 2021
Validation of the Prevention Impacts Simulation Model (PRISM)
Benjamin Yarnoff, Amanda Honeycutt, Christina Bradley, et al.
Journal of Medical Economics
|
March 27, 2026
Cost-effectiveness, public health impact, and budget impact of receipt of Pfizer-BioNTech COVID-19 vaccine, LP.8.1-adapted, 2025/2026 formula among adults aged 18 years and older at high risk for severe outcomes from COVID-19 in the United States
Alon Yehoshua, Manuela Di Fusco, Abby E Rudolph, et al.
Journal of Medical Economics
|
November 13, 2024
Public health and economic impact of COVID-19 vaccination with the Pfizer-BioNTech COVID-19 Vaccine, KP.2, among adults in 2024/2025 in the United States
Alon Yehoshua, Manuela Di Fusco, Abby E Rudolph, et al.
Diabetes, Obesity & Metabolism
|
June 3, 2026
Cost-Effectiveness of NT-proBNP-Guided Cardiovascular Screening in Chinese Adults With Type 2 Diabetes: Real-World Evidence From the Hong Kong Diabetes Biobank
Abby Q Y Li, Benjamin Yarnoff, Claudia H T Tam, et al.
Journal of Medical Economics
|
October 21, 2024
Health outcomes and economic burden among patients with a COVID-19-associated hospitalization in the United States during the predominance of the XBB and JN.1 omicron lineages
Alon Yehoshua, Angela D Cook, Manuela Di Fusco, et al.
Preventing Chronic Disease
|
October 4, 2019
Estimating Costs of Implementing Stroke Systems of Care and Data-Driven Improvements in the Paul Coverdell National Acute Stroke Program
Benjamin Yarnoff, Olga Khavjou, Joanna Elmi, et al.
Expert Review of Vaccines
|
December 17, 2022
Estimated global public health and economic impact of COVID-19 vaccines in the pre-omicron era using real-world empirical data
Jingyan Yang, Shailja Vaghela, Benjamin Yarnoff, et al.
Expert Review of Vaccines
|
December 7, 2024
Modeling the potential public health and economic impact of different COVID-19 vaccination strategies with an adapted vaccine in the Kingdom of Saudi Arabia
Nadine Al Akoury, Julia Spinardi, Hammam Haridy, et al.
Expert Review of Vaccines
|
June 26, 2026
Modeling the potential public health and economic impact and cost-effectiveness of vaccination strategies using an adapted COVID-19 vaccine in the Dominican Republic
Carlos Fernando Mendoza, Juan José Baldi-Castro, Moe H Kyaw, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 34) with videos related to
Sort By:
Page
of 4
BMJ Open
|
January 31, 2024
Descriptive analysis to assess seasonal patterns of COVID-19 and influenza in low-income and middle-income countries in Asia, the Middle East and Latin America
Moe H Kyaw, Julia Regazzini Spinardi, Oladayo Jagun, et al.
Preventing Chronic Disease
|
February 5, 2021
Validation of the Prevention Impacts Simulation Model (PRISM)
Benjamin Yarnoff, Amanda Honeycutt, Christina Bradley, et al.
Journal of Medical Economics
|
March 27, 2026
Cost-effectiveness, public health impact, and budget impact of receipt of Pfizer-BioNTech COVID-19 vaccine, LP.8.1-adapted, 2025/2026 formula among adults aged 18 years and older at high risk for severe outcomes from COVID-19 in the United States
Alon Yehoshua, Manuela Di Fusco, Abby E Rudolph, et al.
Journal of Medical Economics
|
November 13, 2024
Public health and economic impact of COVID-19 vaccination with the Pfizer-BioNTech COVID-19 Vaccine, KP.2, among adults in 2024/2025 in the United States
Alon Yehoshua, Manuela Di Fusco, Abby E Rudolph, et al.
Diabetes, Obesity & Metabolism
|
June 3, 2026
Cost-Effectiveness of NT-proBNP-Guided Cardiovascular Screening in Chinese Adults With Type 2 Diabetes: Real-World Evidence From the Hong Kong Diabetes Biobank
Abby Q Y Li, Benjamin Yarnoff, Claudia H T Tam, et al.
Journal of Medical Economics
|
October 21, 2024
Health outcomes and economic burden among patients with a COVID-19-associated hospitalization in the United States during the predominance of the XBB and JN.1 omicron lineages
Alon Yehoshua, Angela D Cook, Manuela Di Fusco, et al.
Preventing Chronic Disease
|
October 4, 2019
Estimating Costs of Implementing Stroke Systems of Care and Data-Driven Improvements in the Paul Coverdell National Acute Stroke Program
Benjamin Yarnoff, Olga Khavjou, Joanna Elmi, et al.
Expert Review of Vaccines
|
December 17, 2022
Estimated global public health and economic impact of COVID-19 vaccines in the pre-omicron era using real-world empirical data
Jingyan Yang, Shailja Vaghela, Benjamin Yarnoff, et al.
Expert Review of Vaccines
|
December 7, 2024
Modeling the potential public health and economic impact of different COVID-19 vaccination strategies with an adapted vaccine in the Kingdom of Saudi Arabia
Nadine Al Akoury, Julia Spinardi, Hammam Haridy, et al.
Expert Review of Vaccines
|
June 26, 2026
Modeling the potential public health and economic impact and cost-effectiveness of vaccination strategies using an adapted COVID-19 vaccine in the Dominican Republic
Carlos Fernando Mendoza, Juan José Baldi-Castro, Moe H Kyaw, et al.
Page
of 4